MAP2K1 and melanoma: The third-generation inhibitors such as BEZ-235 and Omipalisib in combination with the kinase inhibitor MEK1/2- AS-703026 caused the highest increase (about 3.5–4 times higher than the control) in the activation of the apoptotic process in melanoma cells.